Curaleaf Holdings (CURLF) Capital Expenditures (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Capital Expenditures of $80.7 million for Q4 2024, up 56.37% year-on-year from $51.6 million in Q1 2024, and up 390.53% on a QoQ basis from -$27.8 million in Q3 2024.

Curaleaf Holdings (CURLF) Capital Expenditures (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Capital Expenditures for 6 consecutive years, with $80.7 million the latest figure, recorded in Q4 2024.

  • Quarterly Capital Expenditures rose 56.37% year-over-year to $80.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $89.2 million (down 63.67% YoY) and the FY2025 annual result came in at $2.8 million, down 81.78% from the prior year.
  • Capital Expenditures climbed to $80.7 million in Q4 2024 per CURLF's latest filing, from -$27.8 million in the prior quarter.
  • Over the last five years, Capital Expenditures for CURLF reached as high as $239.6 million in Q4 2022 and fell as low as -$54.6 million in Q4 2021.
  • A 5-year average of $14.9 million and a median of -$27.8 million in 2024 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2021 — Capital Expenditures slumped 135.6% — and 2022, when it soared 538.92%.
  • Year by year, Capital Expenditures stood at $196.5 million in 2020, then slumped by 127.79% to -$54.6 million in 2021, then surged by 538.92% to $239.6 million in 2022, then slumped by 78.45% to $51.6 million in 2023, then surged by 56.37% to $80.7 million in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $80.7 million, -$27.8 million, and $51.6 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 80.75 Mn
Dec 31, 2024 80.75 Mn
Sep 30, 2024 -27.79 Mn
Sep 30, 2024 -27.79 Mn
Dec 31, 2023 51.64 Mn
Dec 31, 2023 51.64 Mn
Sep 30, 2023 -15.36 Mn
Sep 30, 2023 -15.36 Mn
Dec 31, 2022 239.63 Mn
Dec 31, 2022 239.63 Mn
Jun 30, 2022 -30.30 Mn
Jun 30, 2022 -30.30 Mn
Mar 31, 2022 -29.95 Mn
Mar 31, 2022 -29.95 Mn
Dec 31, 2021 -54.59 Mn
Dec 31, 2021 -54.59 Mn
Sep 30, 2021 -44.02 Mn
Sep 30, 2021 -44.02 Mn
Jun 30, 2021 -41.92 Mn
Jun 30, 2021 -41.92 Mn